- Case report
- Open Access
Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report
BMC Pediatrics volume 20, Article number: 287 (2020)
Bainbridge–Ropers syndrome (BRPS) is a recently described developmental disorder caused by de novo truncating mutations in the Additional sex combs-like 3 (ASXL3) gene. Only four cases have been reported in China and are limited to the analysis of its clinical abnormalities, medical imaging features and gene variation. The aim of this study was to investigate the clinical phenotype, imaging manifestations and genetic characteristics of BPRS syndrome caused by ASXL3 gene mutation. Clinical data, medical imaging data and gene test results of BRPS in infant patients were retrospectively analyzed, and related literature was summarized.
At the age of 8 months, brain MRI showed that the subarachnoid space of the forehead was widened, part of the sulci was deepened, and the corpus callosum was thin. The development quotient (DQ) was determined using the 0~6-year-old pediatric examination table of neuropsychological development at 6 months and 8 months. The DQ of both tests was less than 69. Whole-exome sequencing revealed a heterozygous frameshift mutation c.3493_3494deTG in exon 12 of the ASXL3 gene, resulting in the amino acid change p. (Cys1165Ter). No variation was present at this site in her parents. Sanger sequencing of family members validated this analysis, suggesting a de novo mutation. The de novo ASXL3 mutations generated stop codons and were predicted, in silico, to generate a truncated ASXL3.
The main clinical features of the patient included psychomotor development retardation, difficulty in feeding, hypotonia, and special facial features. MRI features showed that brain development lagged behind that of normal children. Genetic testing is helpful in the early diagnosis of BRPS.
Bainbridge–Ropers syndrome (BRPS; OMIM:615485) was first described in 2013 and is characterized by failure to thrive, feeding problems, hypotonia, intellectual disability (ID), autism, postnatal growth retardation, abnormal facial features with arched eyebrows, anteverted nares and delays in language acquisition . A reverse-genetics approach has suggested proven particularly important for the discovery of disorders such as BRPS, whose main clinical features are nonspecific, especially when looked at in isolation or in a small number of patients. De novo mutation status is the first clue to the potential pathogenicity of a given variant, and such mutations are known to constitute a significant proportion of the underlying causes of moderate and severe ID .
BRPS is caused by de novo dominant truncating variants in the transcriptional regulator gene Additional Sex Combs Like 3 (ASXL3), and missense variants in ASXL3 have been identified in individuals with autism spectrum disorder (ASD) [3,4,5]. ASXL family members are assumed to be epigenetic regulators that are involved in hereditary neurological disorders as well as malignancies [6,7,8]. Truncating mutations in ASXL1 have been reported in association with Bohring-Opitz syndrome (BOS), which has phenotypic overlap with BRPS . Both, ASXL1 and ASXL3, are expressed in tissues like brain, spinal cord, kidney, liver and bone marrow, but ASXL3 is expressed a lower level . The high correlation of expression patterns between ASXL1 and ASXL3 may account for some of the shared phenotypic features.
BRPS is very rare worldwide; over 30 cases of BRPS have been reported abroad, and four cases have been reported in China, which were limited to the analysis of the clinical characteristics and genetic characteristics [6, 11]. We report a case of BRPS in Shandong Province and describe the clinical abnormalities, medical imaging characteristics and genetic characteristics of this disease through a literature review to improve the comprehensive understanding of this disease for pediatricians and radiologists.
The patient (female, 6 months) was treated for “psychomotor retardation for more than 3 months”.
The patient mother was primiparous and had been pregnant at the age of 29 years. She denied any exposure to poisons, chemicals and radiation during pregnancy and regular prenatal examinations. At 36 weeks, the patient was delivered by cesarean section due to “breech and intrauterine distress” (poor fetal heart monitoring response), and her crying was weak 1.5 h after birth. There was no premature rupture of membranes, no history of postnatal asphyxia, and no abnormality in amniotic fluid, placenta or umbilical cord. Her Apgar score was 10 points 1 min and 5 min after birth, and she weighed 2.9 kg at birth.
At the age of 6 months, the child could not lift her head, and the rehabilitation treatment was performed for 1 month with poor effect. Neuropsychological tests were performed at the age of 6 months, indicating overall backward development, and she was admitted to the hospital for examination. Admission examination: 70 cm height (normal value at the same age, 67.3 cm), 6.4 kg weight (normal value at the same age, 7.6 kg), 45 cm head circumference (normal value at the same age, 42.8 cm), backward development, malnutrition, general mental reaction, normal skin color, no yellow dye, large and round bilateral pupil, no sensitivity to light reflection on left side, can pursue things, and response to sound. Prominent forehead, protruding superior orbital crest, strabismus, nose unprecedentedly tilted, middle flat, lower lip eversion, and small jaw were observed (Fig. 1). Breath was a little short, double lung breath sound was thick, and cardiac auscultation was normal. Abdomen was smooth and soft; subcutaneous fat was thin; liver, spleen and ribs were not touched; the whole body muscle strength, muscle tension was low; could not raise head and lift the chest while lying on the stomach; fingers were slender; flexion in both hands was clonic; could not make a fist; pendulous wrist; and the wrist had ulnar flexion. Physiological reflex existed, but pathological reflex was not induced.
The parents of the patient were in good health and deny inbreeding and reproduction of similar disabled patients in their family.
The patient underwent brain MRI to assess brain development. In addition, X-ray examination of both the lower limbs and chest was performed to evaluate bone development. All MRI was performed using a 1.5-T MR scanner (Achieva, Philips Medical Systems) and a 16-channel phased array head coil with T2WI, T1WI, T2-FLAIR, DWI sequences with a field of view (FOV) of 230 × 190 mm2, slice thickness of 5 mm, gap of 0.5 mm, axial scanning, and T2WI sagittal sections. The scan time was approximately 10 min. Each image was evaluated by a senior neurologist who was unaware of the established diagnosis. There are several reported scoring schemes for the severity of cortical atrophy and ventricular dilation, such as the semiquantitative ten-point scale devised by Yue et al.  and the ARWMC rating scale by Wahlund LO . After reference to the evaluation criteria proposed in the above two documents, the neuroradiologist used a simpler scheme and scored the findings as mild, moderate or severe based on gross visual assessment.
Genetic tests and laboratory examination
After informed consent was obtained from the parents, 2 ml of peripheral blood was extracted from the child and her parents, and total exon target region capture and high-throughput sequencing were used for detection. The patient was screened for hematuria and genetic metabolic disease.
The neuropsychological test was the 0~6-year-old pediatric examination table of neuropsychological development (Institute of Pediatrics of Capital Medical University, CNBSR 2016). Children are considered to have a developmental concern if their development quotient (DQ) in any specific domain is ≤69. The following classification standard was used: ≥130, excellent; 115–129, intelligent; 84–114, normal; 70–84, lower than normal and ≤ 69, low.
At the age of 8 months, brain MRI showed that the subarachnoid space of the forehead was widened, part of the sulci was deepened, the corpus callosum was thin, no significant high signal was observed in the white matter of the brain, and no significant abnormal high signal was observed on DWI (b = 1000). A detailed assessment of the MRI results is shown in Table 1 and Fig. 2. X-ray examination of both the lower limbs and chest is shown in Fig. 3. Electroencephalogram (EEG) was normal, with no epileptic discharge. A bilateral adrenal CT scan showed no obvious abnormality.
The DQ was determined using the 0~6-year-old pediatric examination table of neuropsychological development (CNBSR 2016) at 6 months and 8 months, as shown in Table 1. The DQ of both tests was less than 69.
Routine test results for hematuria and feces, liver and kidney function, electrolytes and myocardial enzymes were normal. There were no abnormalities in thyroid function and no abnormalities in blood ammonia and lactic acid. There were no abnormalities in parathyroid hormone, 25-hydroxyvitamin D or blood tandem mass spectrometry.
Whole-exome sequencing revealed a heterozygous frameshift mutation c.3493_3494deTG in exon 12 of the ASXL3 gene, resulting in the amino acid change p.(Cys1165Ter). No variation was present at this site in her parents. Sanger sequencing of family members validated this analysis, suggesting a de novo mutation (Fig. 4). The de novo ASXL3 mutations generated stop codons and were predicted, in silico, to generate a truncated ASXL3. These variants are found at low frequency within healthy control populations. The predicted results of SIFT, PolyPhen-2, Mutation Taster, GERP++, and REVEL were unknown. According to the 2015 ACMG Guidelines , the c.3493_3494del mutation is pathogenic.
Discussion and conclusions
ASXL3, the pathogenic gene of rare BRPS, is a member of the ASXL gene family, located at 18q12.1, with a length of 6.8 kb, containing 12 exons and encoding the multicomb protein. The polycarpus family is a group of transcription factors that regulate target genes at the chromatin level through epigenetic modification, and they are involved in embryonic development, cell proliferation, and tumor formation . Missense variations in the ASXL3 gene are closely associated with autism spectrum disorders, and dysfunction variants can lead to severe psychomotor retardation [16, 17]. BRPS and Bohring-Opitz syndrome (BOS) are both genetic diseases with ASXL gene abnormalities , which are difficult to distinguish in clinical practice and can manifest as severe psychomotor retardation, difficulty in feeding, hypotonia and microcephaly [19, 20]. With the increase in cases of BRPS syndrome reported in recent years, the clinical manifestations of the two diseases have also been found to be different. BOS syndrome is usually accompanied by intrauterine growth restriction, with typical special phenotypes, such as triangular head, eyeball protrusion, facial bright red spot mole, upper eyelid oblique and elbow flexion [20, 21]. Although the child in this case was born by cesarean section at 36 weeks due to “breach-position and intrauterine distress”, she did not have the above special face after birth (Fig. 1). In our case, WES revealed a de novo heterozygous frameshift variant in exon 12 of the ASXL3 gene [chr18:31323305-31323306delTG: c.3493_3494del TG, p.(Cys1165Ter)]. The amino acid change in codon 1165 of ASXL3 was previously reported in a Russian female by Kuechler et al. [chr18:g.31,323,306_31,323,307delGT, c.3494_3495delGT, p.(Cys1165Ter)] . Although the two mutations have different chromosomal locations, they both cause the protein to terminate at the same site. In the previous literature, it was reported that a Russian patient was close to the gene mutation site in this study and had facial symptoms similar to those in this study. The Russian girl showed abnormally clenched hands with ulnar deviation and a high palate. Her face was long with a prominent forehead, temporal narrowing, down slanting palpebral fissures, prominent columella and small alae nasi and downturned corners of the mouth. She had long and slender hands/fingers, still with some intermittent ulnar deviation, muscular hypotonia of the trunk and rather hypertonic extremities. The comparison of the clinical manifestations of the two patients indicates that there may be some correlation between similar gene mutation sites and clinical manifestations.
The clinical phenotype of BPRS is complex. Among the more than 30 patients with detailed clinical data worldwide, in addition to psychomotor retardation and severe language impairment, they also presented with multiple symptoms. Even though they carry the same ASXL3 gene mutation sites in patients, the clinical characteristics also differ; Srivastava  and Balasubramanian  reported that they found the ASXL3 gene c.4330C > T nonsense mutations in two patients; one patients has fetal intrauterine growth restriction, feeding difficulties, convulsions, and loss of language, while the other patient does not have these symptoms and can speak simple words. The child in our research was born by cesarean section at 36 weeks due to “breach-position and intrauterine distress”. When she came to the hospital, her height were normal, but her weight was lower than normal. After birth, the child had poor sleep, easy waking, high muscle tension, and difficulty feeding, suggesting that the child may have suffered from vegetative nerve dysfunction before and after birth.
During the treatment of this patient since admission, we always used the DQ test to evaluate the developmental status of the patient. The neuropsychological test was the 0~6-year-old pediatric examination table of neuropsychological development. According to the current two tests, the DQ value of the patient was significantly lower than the normal value, as shown in Table 1. There was no significant change or increase in the two measurements of the DQ value. We will follow up the test in future treatment and see the correlation between changes in brain MRI performance and changes in DQ.
In the previous literature, relatively complete brain MRI data of three patients were presented, with the primary understanding of brain characteristics of BRPS patients based on MRI data. Mild white matter reduction, thinner corpus callosum, mild lateral ventricle enlargement and cerebellar vermis dysplasia were the main manifestations of MRI results in the three patients. One of the patients also underwent a scan of the susceptibility weighted imaging sequence, showing an irregular hypointensity in the right frontal lobe. The imaging findings of the patient in this study were mainly mild lateral ventricular enlargement. The corpus callosum thinned, and the subarachnoid space widened, which are similar to the imaging findings in the previous literature, but there were no obvious abnormal signals in the brain parenchyma, as shown in Fig. 2. In future follow-up, MRI functional sequence scanning should be added to understand changes in brain structure, oxygen metabolism, water molecule movement and other aspects of patients.
There are few reports of BRPS in China, and it is necessary to collect more cases and increase the ASXL3 gene mutation spectrum of children with BRPS in China to search for the relationship between genotypic and clinical characteristics. Most children show moderate to severe mental disabilities and severe language impairment, and some children have autism, epilepsy, etc. . The prognosis of BPRS patients is poor. There is no effective treatment for BPRS, so only symptomatic treatment can be conducted. For example, rehabilitation treatment for psychomotor retardation in the early stage is conducted, and the specific effect needs to be verified by long-term follow-up data. Clinical features of BPRS like feeding difficulties, growth disorders, developmental delays and special faces of children, should be identified as soon as possible to improve the genetic examination and clear diagnosis.
The main clinical features of the patient included psychomotor development retardation, difficulty in feeding, hypotonia, and special facial features. MRI features showed that brain development lagged behind that of normal children. The mutation site in the ASXL3 gene in this patient was first reported in China, and the mutation in the ASXL3 gene c.3393_3494 > T was the pathogenic cause of BRPS this child. The pathogenic variation in the ASXL3 gene was new and functionally deficient.
Additional sex combs-like 3
Field of view
Russell B, Graham JM. Expanding our knowledge of conditions associated with the ASXL gene family. Genome Med. 2013;5:16.
Ramu A, Noordam MJ, Schwartz RS, Wuster A, Hurles ME, Cartwright RA, et al. DeNovoGear: de novo indel and point mutation discovery and phasing. Nat Methods. 2013;10:985–7.
De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209–U119.
Hori I, Miya F, Ohashi K, Negishi Y, Hattori A, Ando N, et al. Novel splicing mutation in the ASXL3 gene causing Bainbridge-ropers syndrome. Am J Med Genet A. 2016;170(7):1863–7.
Shashi V, Pena LDM, Kim K, Burton B, Hempel M, Schoch K, et al. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. Am J Hum Genet. 2017;100(1):179.
Balasubramanian M, Willoughby J, Fry AE, Weber A, Firth HV, Deshpande C, et al. Delineating the phenotypic spectrum of Bainbridge-ropers syndrome: 12 new patients with de novo, heterozygous, loss-of-function mutations in ASXL3 and review of published literature. J Med Genet. 2017;54(8):537–43.
Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N, et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2009;145(6):788–800.
Katoh M. Functional and cancer genomics of ASXL family members. Br J Cancer. 2013;109(2):299–306.
Hoischen A, van Bon BWM, Rodriguez-Santiago B, Gilissen C, Vissers L, de Vries P, et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet. 2011;43(8):729–31.
SSahtoe DD, van Dijk WJ, Ekkebus R, Ovaa H, Sixma TK. BAP1/ASXL1 recruitment and activation for H2A deubiquitination. Nat Commun. 2016;7:10292.
Zhang R, He XH, Lin HY, Yang XH. Bainbridge-ropers syndrome with ASXL3 gene variation in a child and literature review. Zhonghua Er Ke Za Zhi. 2018;56(2):138–41.
Yue NC, Arnold AM, Longstreth WT, Elster AD, Jungreis CA, Oleary DH, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology. 1997;202(1):33–9.
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
Micol JB, Abdel-Wahab O. The role of additional sex combs-like proteins in cancer. Cold Spring Harb Perspect Med. 2016;6(10):a026526.
Srivastava A, Ritesh KC, Tsan YC, Liao R, Su FY, Cao XH, et al. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-ropers syndrome. Hum Mol Genet. 2016;25(3):597–608.
Dangiolo SB, Wilson A, Jobanputra V, Anyane-Yeboa K. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome. Am J Med Genet A. 2015;167a(12):3161–6.
Nakane T, Kubota T, Fukushima Y, Hata Y, Ishii J, Komiyama A. Opitz trigonocephaly (C)-like syndrome, or Bohring-Opitz syndrome: another example. Am J Med Genet. 2000;92(5):361–2.
Urreizti R, Gursoy S, Castilla-Vallmanya L, Cunill G, Rabionet R, Ercal D, et al. The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring-Opitz syndrome. Clin Case Rep. 2018;6(8):1452–6.
Bedoukian E, Copenheaver D, Bale S, Deardorff M. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother. Am J Med Genet A. 2018;176(5):1249–52.
Kibe M, Ibara S, Inagaki H, Kato T, Kurahashi H, Ikeda T. Lethal persistent pulmonary hypertension of the newborn in Bohring-Opitz syndrome. Am J Med Genet A. 2018;176(5):1245–8.
Kuechler A, Czeschik JC, Graf E, Grasshoff U, Huffmeier U, Busa T, et al. Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition. Eur J Hum Genet. 2017;25(2):183–91.
Ethics approval and consent to participate
All study procedures were approved by the Ethical Committee of Jinan Maternal and Child Care Hospital. The patients legal guardian provided informed consent for publication.
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Consent for publication
Written informed consent was obtained from the patient’s parent or guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
This work was supported by a grant from Jinan Scientific and Technological Development Program (CN) (201301049, 201602206, 201907052), Medical and health science and technology development project of Shandong province (2016WS0529).
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yang, L., Guo, B., Zhu, W. et al. Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report. BMC Pediatr 20, 287 (2020). https://doi.org/10.1186/s12887-020-02027-7
- ASXL3 gene
- Bainbridge–ropers syndrome
- Psychomotor retardation
- Magnetic resonance imaging
- Whole-exome sequencing